NRC Health (NRC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $563.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
NRC Health (NRC) Earnings: Report Dates and Results
NRC Health (NRC) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, NRC Health reported EPS of $0.21, in line with the $0.21 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NRC has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Mar 31, 2027 is 64.3% above the $0.14 reported for the quarter ended Mar 31, 2026.
NRC Earnings Call
The latest NRC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 18 quarters below that had an estimate, NRC beat 10, missed 4 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $38.40M, up 11.0% from $34.61M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.21 | $0.21 | $0.21 - $0.21 | 0.00% | In line | +16.3% | 1 | 0 up, 0 down | Oct 27, 2026 | $38.40M |
| Jun 30, 2026 | $0.31 | $0.14 | $0.14 - $0.14 | +121.43% | Beat | N/A | 1 | 0 up, 0 down | Jul 28, 2026 | $35.39M |
| Mar 31, 2026 | $0.14 | N/A | N/A | N/A | N/A | -44.0% | N/A | N/A | Apr 28, 2026 | $34.80M |
| Dec 31, 2025 | $0.08 | N/A | N/A | N/A | N/A | -70.7% | N/A | N/A | Feb 3, 2026 | $35.19M |
| Sep 30, 2025 | $0.18 | N/A | N/A | N/A | N/A | -24.6% | N/A | N/A | Oct 27, 2025 | $34.61M |
| Jun 30, 2025 | -$0.01 | N/A | N/A | N/A | N/A | -103.9% | N/A | N/A | Jul 28, 2025 | $34.04M |
| Mar 31, 2025 | $0.25 | N/A | N/A | N/A | N/A | -5.1% | N/A | N/A | Apr 28, 2025 | $33.55M |
| Dec 31, 2024 | $0.28 | N/A | N/A | N/A | N/A | -22.0% | N/A | N/A | Feb 11, 2025 | $36.91M |
| Sep 30, 2024 | $0.24 | N/A | N/A | N/A | N/A | -25.2% | N/A | N/A | Oct 25, 2024 | $35.82M |
| Jun 30, 2024 | $0.26 | N/A | N/A | N/A | N/A | -11.0% | N/A | N/A | Aug 6, 2024 | $35.02M |
| Mar 31, 2024 | $0.27 | N/A | N/A | N/A | N/A | -5.3% | N/A | N/A | May 7, 2024 | $35.31M |
| Dec 31, 2023 | $0.36 | $0.36 | N/A | 0.00% | In line | +33.3% | N/A | N/A | Feb 13, 2024 | $38.00M |
| Sep 30, 2023 | $0.32 | $0.32 | N/A | 0.00% | In line | -3.0% | N/A | N/A | Nov 7, 2023 | $37.95M |
| Jun 30, 2023 | $0.29 | $0.29 | N/A | 0.00% | In line | -12.1% | N/A | N/A | Aug 1, 2023 | $36.16M |
| Mar 31, 2023 | $0.28 | N/A | N/A | N/A | N/A | -17.6% | N/A | N/A | May 2, 2023 | $36.47M |
| Dec 31, 2022 | $0.27 | N/A | N/A | N/A | N/A | -28.9% | N/A | N/A | Feb 14, 2023 | $38.14M |
| Sep 30, 2022 | $0.33 | N/A | N/A | N/A | N/A | -13.2% | N/A | N/A | Nov 1, 2022 | $37.69M |
| Jun 30, 2022 | $0.33 | N/A | N/A | N/A | N/A | -5.7% | N/A | N/A | Aug 2, 2022 | $37.29M |
| Mar 31, 2022 | $0.34 | N/A | N/A | N/A | N/A | -5.6% | N/A | N/A | May 3, 2022 | $38.44M |
| Dec 31, 2021 | $0.38 | N/A | N/A | N/A | N/A | +18.8% | N/A | N/A | Feb 8, 2022 | $38.30M |
| Sep 30, 2021 | $0.38 | N/A | N/A | N/A | N/A | +2.7% | N/A | N/A | Nov 2, 2021 | $37.77M |
| Jun 30, 2021 | $0.35 | N/A | N/A | N/A | N/A | +16.7% | N/A | N/A | Aug 3, 2021 | $36.42M |
| Mar 31, 2021 | $0.36 | N/A | N/A | N/A | N/A | -21.7% | N/A | N/A | May 4, 2021 | $35.46M |
| Dec 31, 2020 | $0.32 | N/A | N/A | N/A | N/A | -5.9% | N/A | N/A | Feb 9, 2021 | $34.77M |
| Sep 30, 2020 | $0.37 | N/A | N/A | N/A | N/A | +19.4% | N/A | N/A | Nov 3, 2020 | $33.48M |
| Jun 30, 2020 | $0.30 | N/A | N/A | N/A | N/A | +3.4% | N/A | N/A | Aug 4, 2020 | $31.17M |
| Mar 31, 2020 | $0.46 | N/A | N/A | N/A | N/A | +43.8% | N/A | N/A | May 5, 2020 | $33.86M |
| Dec 31, 2019 | $0.34 | $0.30 | N/A | +13.33% | Beat | +13.3% | N/A | 0 up, 0 down | Feb 11, 2020 | $32.62M |
| Sep 30, 2019 | $0.31 | $0.29 | N/A | +6.90% | Beat | +14.8% | N/A | 0 up, 0 down | Nov 5, 2019 | $32.47M |
| Jun 30, 2019 | $0.29 | $0.26 | $0.26 - $0.26 | +11.54% | Beat | +3.6% | 1 | N/A | Aug 6, 2019 | $31.41M |
| Mar 31, 2019 | $0.32 | $0.31 | N/A | +3.23% | Beat | +10.3% | N/A | N/A | May 7, 2019 | $31.48M |
| Dec 31, 2018 | $0.30 | $1.05 | N/A | -71.43% | Miss | +100.0% | N/A | N/A | Feb 12, 2019 | $30.64M |
| Sep 30, 2018 | $0.27 | $0.98 | N/A | -72.45% | Miss | +68.8% | N/A | N/A | Nov 6, 2018 | $30.01M |
| Jun 30, 2018 | $0.28 | $0.22 | N/A | +27.27% | Beat | +21.7% | 1 | N/A | Aug 7, 2018 | $28.02M |
| Mar 31, 2018 | $0.29 | $0.25 | N/A | +16.00% | Beat | +11.5% | 1 | N/A | May 1, 2018 | $31.02M |
| Dec 31, 2017 | $0.15 | $0.22 | N/A | -31.82% | Miss | -37.5% | N/A | N/A | Feb 13, 2018 | $29.90M |
| Sep 30, 2017 | $0.16 | $0.21 | N/A | -23.81% | Miss | -15.8% | N/A | N/A | Nov 7, 2017 | $28.95M |
| Jun 30, 2017 | $0.23 | $0.20 | N/A | +15.00% | Beat | +109.1% | N/A | N/A | Aug 1, 2017 | $28.43M |
| Mar 31, 2017 | $0.26 | $0.24 | N/A | +8.33% | Beat | +116.7% | N/A | N/A | May 2, 2017 | $30.28M |
| Dec 31, 2016 | $0.24 | $0.22 | N/A | +9.09% | Beat | 0.0% | N/A | N/A | Feb 21, 2017 | $28.37M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.50, down 51.6% from the year before. It was $0.66 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.50 | -51.6% |
| Dec 31, 2024 | $1.04 | -16.5% |
| Dec 31, 2023 | $1.25 | N/A |
| Dec 31, 2022 | $1.27 | -13.6% |
| Dec 31, 2021 | $1.47 | N/A |
| Dec 31, 2020 | $1.45 | +15.1% |
| Dec 31, 2019 | $1.26 | +10.5% |
| Dec 31, 2018 | $1.14 | +42.5% |
| Dec 31, 2017 | $0.80 | +21.2% |
| Dec 31, 2016 | $0.66 | N/A |
Earnings Calls
The 2 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,700 words across 8 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,691 | 8 | |
| 2025Q4 | Dec 31, 2025 | 2,413 | 4 |
2026Q3 Earnings Call
Opening remarks
Jordan N. Freeman Chief Accounting Officer Thank you, operator. Welcome to NRC Health's earnings conference call for the second quarter ended June 30, 2026. I wanted to first let you know that we posted our earnings press release to the Investor Relations section on our website. On this call today, we have NRC Health's CEO, Trent Green, and CFO, Shane R. Harrison. Today's call will include statements related to the expected future results of our company, which are therefore forward-looking statements. Actual results may differ materially from these expectations due to a number of risks and uncertainties, including those described in our earnings release and other SEC filings. We will also reference non-GAAP financial measures. Definitions and reconciliations to the most comparable GAAP measures are provided in our earnings press release, which is available on our Investor Relations website. A replay of this call will also be posted to the same website. With that, let me turn our call over to our CEO, Trent Green.
Trent Green CEO Thank you, Jordan. Good afternoon, everyone. Thank you for joining us for NRC Health's second quarter 2026 earnings call. Today, I will begin with an overview of our second quarter performance, discuss the momentum we are seeing across the business, and highlight how we continue to advance the next chapter of the NRC Health story with innovation across our product portfolio. We delivered another strong quarter of execution in the second quarter, reflected in our year-over-year total recurring contract value, or TRCV, and revenue growth. During the quarter, TRCV increased 11% year over year, with diversified growth across the business. Experience TRCV grew in the mid-teens compared to the prior year, driven by strong bookings activity during the first half of this year. Also notable in the quarter was the Governance Institute, which achieved its strongest bookings performance in seven years and grew its TRCV by nearly 10% year over year. This performance reinforces our conviction that healthcare leaders increasingly value trusted strategic guidance alongside technology-enabled solutions. Our TRCV growth reflects more than market demand. It demonstrates the effectiveness of our strategy. The sales organization we redesigned around buyers continues to perform well, enabling deeper engagement across experience, market insights, and the Governance Institute. By aligning with how health systems make decisions, we are creating larger, more strategic relationships and expanding our opportunity to deliver value across the enterprise. We are also seeing encouraging returns from our continued product investments, particularly those that connect experience measurement with experience improvement. Those capabilities were a key differentiator in the Landmark multisolution agreement we discussed last quarter and continue to resonate with healthcare organizations looking for partners who can move beyond insight to measurable action.
Frequently Asked Questions About NRC
When is NRC Health's next earnings date?
NRC Health's next earnings report is expected for Feb 1, 2027.
Did NRC beat earnings estimates last quarter?
NRC Health reported EPS of $0.21 for the quarter ended Sep 30, 2026, in line with the $0.21 estimate.
What EPS do analysts expect from NRC next quarter?
The consensus EPS estimate for NRC Health for the quarter ending Mar 31, 2027 is $0.23 from 1 analyst, with estimates from $0.23 to $0.23.
How often does NRC beat earnings estimates?
NRC Health beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +19.15%.
NRC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors